Arno Therapeutics raises $15 million to fund clinical oncology candidates
This article was originally published in Scrip
Executive Summary
Arno Therapeutics, a private US biopharmaceutical company, has raised $15 million in series A funds to advance its pipeline of cancer therapeutics, two of which are in clinical testing.